123572-64-5

Usage

Uses

Used in Pharmaceutical Industry:
2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and functional groups make it a valuable intermediate in the development of new drugs.
Used in Agrochemical Industry:
2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene is also used as a building block in the synthesis of agrochemicals. Its properties allow for the creation of compounds with potential applications in crop protection and pest control.
Used in Organic Synthesis:
2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene is used as a reagent in organic synthesis. Its versatility and reactivity make it a useful component in the preparation of various organic compounds.
Used in Research:
2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene is utilized in research settings to study the properties and reactions of fluoro-substituted nitrobenzene derivatives. Its unique structure provides opportunities for exploration in various areas of chemistry.

Upstream product

• 1077-01-6 meta-fluoro(trifluoromethoxy)benzene 

Downstream Products

• 1159795-41-1 4-methyl-1-(2-nitro-5-trifluoromethoxy-phenyl)-1H-imidazole 
• 168971-68-4 1-bromo-2-fluoro-4-(trifluoromethoxy)benzene 
• 123572-58-7 2-fluoro-4-(trifluoromethoxy)aniline 

Relevant academic research and scientific papers

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.

ANTIBIOTIC COMPOUNDS

The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.

ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF PHOSPHODIESTERASE 10

The invention relates to imidazo[1,5-a]pyrazine derivatives, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10 (PDE10), as active compounds for treating central nervous system diseases of mammals, including humans.